Management of Congenital Ichthyoses: European Guidelines of Care, Part Two

    J. Mazereeuw‐Hautier, Anders Vahlquist, Heiko Traupe, Anette Bygum, Cristina Amaro, M. Aldwin, A. Audouze, Christine Bodemer, E. Bourrat, Andrea Diociaiuti, Mateja Dolenc‐Voljč, I. Dreyfus, May El Hachem, Judith Fischer, Agneta Gånemo, Christopher J. Gouveia, Robert Gruber, S. Hadj‐Rabia, Daniel Hohl, Nathalie Jonca, Khaled Ezzedine, D. Maier, Raman Malhotra, M. Rodriguez, Hagen Ott, David G. Paige, Aldona Pietrzak, F. Poot, Matthias Schmuth, Jan Cezary Sitek, P.M. Steijlen, G. Wehr, M. Moreen, Edel A. O’Toole, Vinzenz Oji, Ángela Hernández‐Martín
    Image of study
    TLDR European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.
    The document outlines European guidelines for managing congenital ichthyoses (CI), a group of genetic skin disorders. It provides recommendations for various complications associated with CI, such as ophthalmic and ear issues, pruritus, pain, infections, growth and nutritional deficiencies, hair and nail problems, and physical limitations. Specific advice includes regular ophthalmic exams, use of ocular lubricants, hearing evaluations, topical skin care, and oral retinoids for pruritus, as well as monitoring and supplementing vitamin D levels. The guidelines also address the management of CI in neonates, including the care of collodion babies and harlequin ichthyosis, with an emphasis on avoiding certain topical substances and considering oral retinoids for severe cases. For Netherton syndrome, the document suggests limited use of topical steroids and calcineurin inhibitors, cautious phototherapy, and regular dermatological check-ups for skin cancer risks. The recommendations are based on a systematic review of literature, expert conference, and consensus discussions, aiming to improve patient outcomes and quality of life. The evidence for these guidelines is mostly graded as level 3 with a grade of D, indicating moderate evidence and low recommendation strength.
    Discuss this study in the Community →

    Research cited in this study

    5 / 5 results

    Related Community Posts Join

    6 / 12 results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 3 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community I will never more buy any hairloss traitements in public pharmacy

      in Minoxidil  420 upvotes 1 month ago
      A user was embarrassed by a pharmacist's loud mention of "minoxidil" for hair loss, sparking a discussion on the stigma and unprofessionalism. Users suggested online purchases or different pharmacies for privacy and reassured that most people don't notice others' purchases.

      community I was on 2.5 mg oral minoxidil

      in Progress Pictures  468 upvotes 4 months ago
      User took 2.5 mg oral minoxidil, saw hair growth but stopped due to excessive body hair. Recently started finasteride and plans to update progress.

    Similar Research

    5 / 1000+ results
      Index

      research Index

      November 2019 in “Harper's Textbook of Pediatric Dermatology”
      The document is a detailed medical reference on skin and genetic disorders.
      Secondary Cicatricial and Other Permanent Alopecias

      research Secondary Cicatricial and Other Permanent Alopecias

      June 2008 in “Springer eBooks”
      The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."
      Finasteride for Female Androgenetic Alopecia

      research Finasteride for Female Androgenetic Alopecia

      51 citations, October 2002 in “British Journal of Dermatology”
      Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.
      Eyebrow Loss

      research Eyebrow Loss

      29 citations, January 2007 in “American Journal of Clinical Dermatology”
      Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.
      Hair Disorders

      research Hair Disorders

      November 2019 in “Harper's Textbook of Pediatric Dermatology”
      Understanding normal hair growth and loss in children is key to diagnosing and treating hair disorders.